CliffBio
small molecule

ARNUITY ELLIPTA

FLUTICASONE FUROATE

Loss of exclusivity—loss of exclusivity
CompanyGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND

Drug detail

Brand nameARNUITY ELLIPTA
Active ingredientFLUTICASONE FUROATE
Strength0.2MG/INH
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
FDA approvalAugust 2014
Marketing statusRX

More from GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ARNUITY ELLIPTA patent cliff — loss of exclusivity — | CliffBio